References
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136(1):203–14.
Tee AR, Blenis J. mTOR, translational control and human disease. Semin Cell Dev Biol. 2005;16(1):29–37.
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018–24.
Ventura-Aguiar P, Campistol JM, Diekmann F. Safety of mTOR inhibitors in adult solid organ transplantation. Expert Opin Drug Saf. 2016;15(3):303–19.
Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M, et al. Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review. J Vasc Surg. 2020;71(1):318–27.
Acknowledgements
For their editorial assistance, we thank Jenni Weems, MS, Kerry Kennedy, BA, and Rachel Box, MS, in the Editorial Services group of The Johns Hopkins Department of Orthopaedic Surgery.
Funding
This study was supported wholly by NIH T32 Institutional Training Grant T32EB006351-12. The funding body was not involved in the design of the study, collection/analysis/interpretation of the data, or the writing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
C.R.W. is funded by BTG, Siemens, and Medtronic and is a consultant for BTG and Medtronic (all unrelated to this study). The remaining authors have nothing to disclose.
Consent for Publication
Consent for publication was obtained for every individual person’s data included in the study.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional review board approval was waived for this study.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
SIR Annual Scientific Meeting: This has been accepted by SIR as an educational abstract for the 2021 SIR Annual Scientific Meeting.
Rights and permissions
About this article
Cite this article
Yuan, F., Bailey, C.R., Khalil, A. et al. Emerging Role of Sirolimus in the Treatment of Diffuse Venous Malformation in a Woman with Klippel-Trenaunay Syndrome. Cardiovasc Intervent Radiol 44, 1672–1674 (2021). https://doi.org/10.1007/s00270-021-02902-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-021-02902-5